Controlled Modulation of BBB Permeability Using the Bradykinin Agonist, RMP-7

Author： Bartus R.T.   Elliott P.J.   Dean R.L.   Hayward N.J.   Nagle T.L.   Huff M.R.   Snodgrass P.A.   Blunt D.G.  

Publisher： Elsevier

ISSN： 0014-4886

Source： Experimental Neurology, Vol.142, Iss.1, 1996-11, pp. : 14-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Unlocking the Blood-Brain Barrier: A Role for RMP-7 in Brain Tumor Therapy

By Elliott P.J.   Hayward N.J.   Huff M.R.   Nagle T.L.   Black K.L.   Bartus R.T.  

Experimental Neurology, Vol. 141, Iss. 2, 1996-10 ,pp. : 214-224

Elsevier

Access to resources Recommend Favorite

Sensory Responses of Neurons in the Medial Septal Area in Conditions of Modulation of Theta Activity Using the Alpha-2-Adrenoreceptor Agonist Clonidine

By Kichigina V. F.   Kutyreva E. S.   Sudnitsyn V. V.  

Neuroscience and Behavioral Physiology, Vol. 35, Iss. 1, 2005-01 ,pp. : 107-116

Springer Publishing Company

Access to resources Recommend Favorite

Overexpression of bradykinin type 2 receptors on glioma cells enhances bradykinin-mediated blood–brain tumor barrier permeability increase

By Uchida Mikito   Chen Zutang   Liu Yunhui   Black Keith L.  

Neurological Research, Vol. 24, Iss. 8, 2002-11 ,pp. : 739-746

Maney Publishing

Access to resources Recommend Favorite

RhoA-Mediated Potential Regulation of Blood–Tumor Barrier Permeability by Bradykinin

By Ma Teng   Xue Yixue  

Journal of Molecular Neuroscience, Vol. 42, Iss. 1, 2010-09 ,pp. : 67-73

Humana Press, Inc

Access to resources Recommend Favorite

Modulation of neuronal CXCR4 by the μ-opioid agonist DAMGO

By Patel Jeegar P   Sengupta Rajarshi   Bardi Giuseppe   Khan Muhammad Z   Mullen-Przeworski Anna   Meucci Olimpia  

Journal of NeuroVirology, Vol. 12, Iss. 6, 2006-12 ,pp. : 492-500

Ashgate Publishing Ltd

Access to resources Recommend Favorite